Stefan Verweij

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Autism Spectrum Disorder

Top Venues

Clinical pharmacology and therapeutics

Applied health economics and health policy

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan Verweij, Vincent Haverhoek, Erik Bergman, Gabriel Westman, Lourens T Bloem
A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process. Clinical pharmacology and therapeutics 115 (4) (2024)
Stefan Verweij, Wouter Ahmed, Guiling Zhou, Dimitris Mavridis, Stavros Nikolakopoulos, Andre J Elferink, Katrien Oude Rengerink, Maarten J Bijlsma, Peter G M Mol, Eelko Hak
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis? Pharmacoepidemiology and drug safety 33 (5) (2024)
Stefan Verweij, Vincent Haverhoek, Erik Bergman, Gabriel Westman, Lourens T Bloem
A Natural Language Processing Approach towards Harmonized Communication of Uncertainties Identified during the European Medicine Authorization Process. Clinical pharmacology and therapeutics (2024)
Stefan Verweij, Vincent Haverhoek, Erik Bergman, Gabriel Westman, Lourens T Bloem
A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process. Clinical pharmacology and therapeutics 115 (4) (2024)
Stefan Verweij, Vincent Haverhoek, Erik Bergman, Gabriel Westman, Lourens T Bloem
A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process. Clinical pharmacology and therapeutics 115 (4) (2024)
Sieta T de Vries, Noral Huda S Al-Mugoter, Irena Petkoska, Stefan Verweij, André J A Elferink, Peter G M Mol
Comment on: "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022". Applied health economics and health policy (2023)